Fecha de publicación: -- Fuente: WIPO "tomato" This disclosure relates to variant AAV9 particles engineered to escape host neutralizing antibodies but retain or improve transduction efficiency, production efficiency and/or infectivity, and their use as gene delivery vehicles.